Expression of transcription factors binding to the activating protein-1 (AP-1) site is induced by estrogens in association with epithelial proliferation in the uterus, but, in the oviduct, the relationship between cell proliferation and differentiation and AP-1 transcription factors is not well understood. In the developing rat oviduct, we found that proliferation and differentiation of epithelial cells were region-dependently regulated by 17 -estradiol (E2). To determine the role of AP-1 transcription factors in the development of rat oviduct, we performed immunohistochemistry for epithelial c-jun and c-fos proteins in E2-untreated and -treated newborn rats. E2 increased the expression of c-jun and c-fos during proliferation of undifferentiated epithelial cells, but diminished both proteins during accelerated differentiation of ciliated epithelial cells. A pure estrogen receptor (ER) antagonist, ICI 182,780, inhibited changes in their expression during both cell proliferation and differentiation. Importantly, no reduction of c-jun was noted in the epithelial cells of the foxj1-deficient oviduct, which lacks cilia development. This study shows that c-jun and c-fos are regulated during epithelial cell proliferation and differentiation in a regionspecific manner. This provides critical information for understanding the molecular and cellular mechanisms of the development of the neonatal oviduct.
Introduction
The development of the female reproductive tract is highly dependent on estrogens that act via estrogen receptors (ER ) and (ER ), which are members of ligand-inducible nuclear transcription factor receptors (Mangelsdorf et al. 1995) . The estrogen and ER complex generate either a homo-or hetero-dimer that binds to the estrogen response element (ERE) sequence on target DNA and can activate transcription of various functional downstream genes. Proto-oncogenes proteins such as c-jun and c-fos are nuclear transcription factors whose homo-or hetero-dimer complex bind to the activating protein-1 (AP-1) site and regulate the cell proliferation, differentiation, and transformation (Angel & Karin 1991) . It has been well documented that the estrogens can regulate the expression of AP-1 transcription factors including c-jun and c-fos by interacting with their functional ERE (Rauscher et al. 1988 , Weisz & Rosales 1990 , Hyder et al. 1992 , Schuchard et al. 1993 , Weisz & Bresciani 1993 . During a normal estrous cycle, the expression of c-fos is regulated in association with cell proliferation, plasma estradiol (E2), and ER expression in the rat luminal epithelium (Mendoza-Rodrí guez et al. 2003) . It is well known that the uterine epithelial cells proliferate due to E2, and that the transcription of c-jun and c-fos genes is rapidly and dramatically induced in the uteri of ovariectomized immature and mature rats and mice treated with E2 or diethylstilbestrol (DES), a synthetic estrogen (Loose-Mitchell et al. 1988 , Weisz & Bresciani 1988 , Webb et al. 1990 , Chiappetta et al. 1992 , Kamiya et al. 1996 . The estrogeninduced expressions of c-jun and c-fos are not prevented by protein synthesis inhibitors, suggesting a primary response to the ER complex. It was demonstrated, despite an increase in c-fos expression after E2 treatment, that E2 reduced c-jun expression in the uterine epithelial cells of immature and adult ovariectomized rodents neonatally treated or untreated with DES (Bigsby & Li 1994 , Yamashita et al. 2001 . Taken together, although there is a discrepancy in the reporting of c-jun changes, these findings suggest that c-jun and c-fos play critical roles in regulating E2-dependent cell proliferation in the uterine epithelium.
Several experimental models on the neonatal oviduct have shown that epithelial cell proliferation is regulated by E2, as in the uterus (Jansen 1984) . Perinatal exposure to DES induced cell proliferation and caused abnormal morphology in mouse and rat oviducts (Newbold et al. 1983 , Okada et al. 2001 . Also, in immature chicks, E2 induced cell proliferation in the oviductal epithelium (Anderson & Hein 1976) . However, unlike in the uterus, the effects of E2 on the expression of AP-1 transcription factors have not been reported in the mammalian oviduct, but only in the immature chick oviduct whose c-jun and c-fos were rather reduced, with increased ovalbumin production, after E2 treatment (Cohrs et al. 1988 , Lau et al. 1990 . It is possible that the discrepancy in AP-1 transcription factor expression between the uterus and the oviduct is related to unique epithelial cells specific to the developing oviduct (Weisz & Bresciani 1993) . However, this hypothesis has not been well demonstrated since previous chick studies were conducted by using a homogenate of the whole oviduct.
The oviduct has more complex morphological features than the uterus, which contains only a single epithelial cell type and lacks regional differences. Within the oviductal lumen, there is regional distribution of at least two types of epithelial cells, ciliated and secretory cells. In addition to cell proliferation, E2 regulates the differentiation of epithelial cells in the oviduct. The appearance of immunoreactivity for -tubulin IV, an epithelial cilia marker protein (Renthal et al. 1993) , occurred on the 7th day after birth (ND 7) and was accelerated by treatment with E2 in neonatal mouse and rat oviducts (Eroschenko 1982 , Abe & Oikawa 1993 ). -tubulin IV-positive epithelial cells appeared in the ND 5 rat oviduct after E2 treatment for 5 days (Okada et al. 2004) . Differentiation of secretory cells was also induced by E2 treatment in the hamster oviduct (Abe & Oikawa 1993) . Moreover, we recently reported that cell proliferation and differentiation of epithelial cells were region-dependently induced at the isthmus/ uterotubal junction (IST/UTJ) and infundibulum/ ampulla (INF/AMP), respectively, in the neonatal rat oviduct treated with E2 for 5 postnatal days (Okada et al. 2004) . We put forward a hypothesis, therefore, that in the neonatal rat oviduct, c-jun and c-fos are expressed regionand cell type-dependently, which were regulated by E2 in association with cell proliferation and differentiation. To demonstrate the detailed expression of epithelial c-jun and c-fos during the neonatal development of the oviduct, immunohistochemical evaluations of protein expression was performed in each region of the neonatal rat oviduct treated with or without E2 for 5 days from the day of birth. We show that c-jun and c-fos regulate region-dependent epithelial cell differentiation during neonatal oviduct development, suggesting that AP-1 transcription factors direct epithelial proliferation and differentiation of the oviduct in response to E2.
Materials and Methods

Animals and treatments
Animals were maintained in accordance with the NIH and the Institutional Guides for the Care and Use of Laboratory Animals. Male and female Sprague-Dawley rats were obtained from Charles River Japan, Inc. (Kanagawa, Japan). Animals were housed individually in stainless-steel cages with controlled temperature (23 2 C) and relative humidity (55 10%), and a 13-h light/11-h dark cycle (8:00-21:00). Pellet food (CRF-1, Oriental Yeast Co., Ltd, Tokyo, Japan) and municipal tap water were freely available. Females (15 weeks of age) were cohabited overnight with males for impregnation. The day on which neonates were born was designated as ND 0. In rat studies, oviducts were removed from untreated neonatal rats on ND 0, 3, 5, 7 and 10. Foxj1-deficient mice (Brody et al. 2000) , and their wild-type littermates were used at 3 weeks of age.
To investigate the effect of E2, 16 to 24 female neonates in each group were injected subcutaneously daily with either sesame oil or 10 µg of E2 (Sigma, St Louis, MO) for 5 days (ND 0 to 4). Similarly, sesame oil or 10 µg of ICI 182,780 (Tocris Cookson, Inc., Ballwin, MO) was concomitantly injected for 5 days (ND 0 to 4). Oviducts were removed 24 h after the last injection (ND 5), and immediately prepared for immunohistochemistry. E2 and ICI were dissolved in sesame oil and injected at 0·05 mL per neonate.
Antibodies
Mouse monoclonal antibodies against proliferating cell nuclear antigen (PCNA) (PC10; Dako Corporation, Carpinteria, CA) and -tubulin IV (ONS1A6; BioGenex, San Ramon, CA) were used at a dilution of 1:100 and 1:250, respectively. A mouse monoclonal antibody against oviductal glycoprotein (OGP), which recognizes proteins with more than 330 kDa of OGP, was purchased from the Institute for Functional Peptide (C8B11; Yamagata, Japan). The binding specificity of these antibodies has been previously established (Bannerjee et al. 1992 . Rabbit polyclonal antibodies against c-jun (H-79) and c-fos (K-25) were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and used at a dilution of 1:100. According to the data sheet provided by the manufacturer, the c-jun antibody reacts with c-jun, but not jun B or jun D, while the c-fos antibody reacts with fos B, fra-1, and fra-2 in addition to c-fos.
Tissue preparation and immunohistochemistry
Neonatal oviducts were fixed with 4% paraformaldehyde in 0·1 M phosphate buffer overnight at 4 C. Paraffinembedded samples cut in 4 µm serial sections were deparaffinized, rehydrated, and autoclaved at 121 C for 15 min in 10 mM citrate buffer (pH 6·0), for antigen retrieval. Sections were then rinsed in distilled water and incubated with 0·3% hydrogen peroxide for 30 min. After rinsing with PBS, sections were treated with normal sheep serum (Dako Corporation, Carpinteria, CA) for 30 min, and then incubated for 30 min with anti-PCNA antibody, for 2 h with anti-OGP antibody, or for 16 h at 4 C with anti-c-jun or c-fos antibody. Sections were rinsed in PBS and treated with Simple Stain Rat MAX-PO (Nichirei, Tokyo, Japan) for 30 min. After a final PBS wash, sections were treated with 0·01% 3,3 -diaminobenzidine tetrahydrochloride (Dojindo Laboratories, Kumamoto, Japan) in 0·05 M Tris-HCl at pH 7·6 containing 0·068% imidazole (Sigma) and 0·02% hydrogen peroxide for 5 min.
For double immunohistochemistry, sections stained for PCNA, c-jun, or c-fos as described above were rinsed in PBS and blocked in normal sheep serum, followed by incubation with the anti--tubulin IV antibody overnight at 4 C. Sections were rinsed in PBS and treated with EnVision/AP (Dako) for 30 min. After rinsing in PBT, they were treated with Fuchsin (Dako) containing levamisole (Dako) for 5 min.
All sections were lightly counter-stained with hematoxylin (Dako A/S, Glostrup, Denmark). Normal mouse IgG and normal rabbit immunoglobulin fraction (both Dako A/S) were used as negative controls in place of primary antibodies for PCNA, -tubulin IV and OGP, and c-jun and c-fos stainings, respectively. In addition, for c-fos immunostaining, sections were also incubated with the anti-c-fos antibody that had been pre-absorbed with c-fos peptide (Santa Cruz) overnight at 4 C. Negative controls showed no specific immunoreactivity in all experiments. Sections were examined and photographed using a lightmicroscope attached to a digital CCD camera (BX60 and DP50, Olympus Optical Co., Ltd, Tokyo, Japan).
Evaluation and statistical analysis
For c-jun and c-fos immunohistochemistry, at least seven specimens from each of five animals were examined, and staining intensity was graded as negative, slight, weak, moderate, or marked. Epithelial cell proliferation was calculated as a percentage of the PCNA-labeled cells in all epithelial cells in each section evaluated. At least five specimens from each of five animals were examined.
Statistical analysis was carried out, using Duncan's multiple comparison test, for the effects of E2 on PCNA expressions. Data are represented as mean SD and considered significantly different at P<0·05.
Results
Epithelial proliferation and differentiation in the untreated-neonatal rat oviduct
To understand the neonatal development of the oviduct, we first evaluated ontogenic proliferation and differentiation of epithelial cells in untreated-neonatal rats. The neonatal oviduct was a simple tube structure from ND 0 to ND 7, and subsequently differentiates morphologically into the INF/AMP and the IST/UTJ. Proliferating epithelial cells were determined by the immunohistochemical detection of PCNA (Table 1 and Fig. 1 ). Epithelial PCNA was expressed in a few cells on ND 0 (8·8%), and was expressed in more cells on ND 5 (23·9%, Fig. 1A) . A decrease in PCNA-expressing cells occurred on ND 7 (18·9%, Fig. 1B) and ND 10 at the INF/AMP region (9·5%, Fig. 1C ). At the IST/UTJ, however, many epithelial cells expressing PCNA were still observed on ND 10 (32·9%, Fig. 1D ). It is evident, then that there are temporal and spatial differences in cell proliferation within the oviduct lumen.
The expression of cilia protein -tubulin IV and oviductal secretory protein OGP was used as a marker of differentiated ciliated and secretory epithelial cells, respectively, and evaluated by immunohistochemistry during neonatal oviduct development. No expression of epithelial -tubulin IV was detected in the oviduct from ND 0 to 5 ( Fig. 2A ). -tubulin IV appeared on the luminal surface of some epithelial cells on ND 7 (Fig. 2B) . After morphological differentiation of the oviduct into different regions, the number of epithelial cells expressing -tubulin IV increased and were numerous in the INF/ AMP on ND 10 (Fig. 2C) . In contrast, no epithelial -tubulin IV-positive cells were found in the IST/UTJ by ND 10 (Fig. 2D ). The expression of OGP was absent from all epithelial cells on ND 0 to 5 (Fig. 2E) , and detected in the cytoplasm of some epithelial cells on ND 7 (Fig. 2F) . Epithelial cells positive for OGP increased on ND 10 at the IST/UTJ (Fig. 2H ) and, however, they did not appear at the INF/AMP region (Fig. 2G) . Thus, regional differentiation into ciliated or secretory epithelial cells in the rat oviduct occurred after ND 5, following active epithelial proliferation.
Ontogeny of epithelial c-jun and c-fos proteins in the untreated-neonatal rat oviduct
To determine if AP-1 proteins regulate regional oviduct differentiation, we determined the expression pattern of c-jun and c-fos during oviduct development (Table 1 ). All epithelial cells showed c-jun and c-fos nuclear expression at a marked level on ND 0 (Table 1) , but on NDs 5 and 7, it decreased to a moderate or slight level (Figs. 3A, 3B , 3E, and 3F). In the INF/AMP on ND 10, epithelial c-jun and c-fos decreased (Figs. 3C and 3G ), however, in the IST/UTJ, moderate or weak expressions were maintained until ND 10 (Figs. 3D and 3H) . Therefore, although the correlation between -tubulin IV-and AP-1 proteinpositive cells was not established in this study, epithelial c-jun and c-fos in the INF/AMP decreased in correlation with reduced cell proliferation and the subsequent differentiation of ciliated cells.
Neonatal effects of E2 on cell proliferation and differentiation of the oviduct
In order to understand the role of E2 on neonatal development of the oviduct, either oil vehicle or 10 µg E2 was injected into neonatal rats for 5 days starting at the day of birth. Also, oil vehicle or pure estrogen receptor antagonist ICI was concomitantly injected with 10 µg E2. We determined the effect of E2 on cell proliferation and differentiation by the double-immunohistochemical detection of PCNA and -tubulin IV or OGP. Following E2 treatment, morphological changes of the primitive oviduct tube into the INF/AMP and IST/UTJ was observed on ND 5 when regional differentiation had not occurred in the untreated oviduct. The oviduct exhibited typical estrogen effects such as hypertrophy of the epithelial and stromal cells, including nuclei enlargement, and dilatation of the lumen in the IST/UTJ. In the oil-treated oviduct group, no cells immunopositive for -tubulin IV were detected on ND 5 (Fig. 4A) . E2 treatment induced epithelial -tubulin IV expression on ND 5 only in the INF/AMP region (Figs. 4B and 4C). Treatment with ICI reduced the percentage of -tubulin IV-expressing epithelial cells within the duct (Fig. 4D ). These observations were in agreement with our previous report (Okada et al. 2004) . In contrast, in the oil-treated ND 5 oviduct, OGP was not observed and E2-treatment did not induce its expression, even in the epithelial cells of the IST/UTJ. In the E2-treated tissues on ND 5, epithelial PCNA was observed in more epithelial cells of the IST/UTJ (36·0%, P<0·05, Fig. 4C ) compared with the oil controls (24·2%, Fig. 4A ), but in the INF/AMP (18·6%, P<0·05, Fig.4B ), there were fewer PCNA-positive cells encountered than in the oil controls. In the INF/AMP, -tubulin IV expression was observed mainly in PCNA-negative cells. Concomitant treatment with ICI retained changes in PCNA made by E2 at the control level (25·6%, Fig. 4D ). These findings, therefore, demonstrate that E2 induces the differentiation of ciliated epithelial cells after the reduction of their proliferation via ER signaling. However, it does not induce the differentiation of secretory epithelial cells in the ND 5 oviduct in our experiment system.
Neonatal effects of E2 on c-jun and c-fos expression in the oviduct
To determine the relationship of AP-1 proteins to region and cell type-dependent proliferation and differentiation of epithelial cells after treatment with E2, c-jun and c-fos expression was immunohistochemically evaluated in the oil-or E2-treated rat oviduct. In the oil-treated ND 5 oviduct, c-jun and c-fos proteins were expressed in the epithelium in a pattern similar to those in the untreated ND 5 tissues (Figs. 5A and 5E ). Following E2 treatment, Figs . 5B and 5F), but unchanged in the IST/UTJ region (Table 1, Figs. 5C and 5G). Concomitant treatment with ICI retained the E2 effects at levels comparable to the oiltreated control (Figs. 5D and 5H ). Thus E2 reduces c-jun and c-fos proteins in association with the promotion of ciliated epithelial cell differentiation in the INF/AMP. While, in the IST/UTJ, epithelial cells proliferated, but they did not differentiate into secretory cells when AP-1 proteins were expressed.
Expression of epithelial c-jun in the oviduct of the foxj1-deficient mice
In order to understand the relationship between the differentiation and the c-jun reduction in ciliated epithelial cells, the expression of c-jun was evaluated in oviducts from 3-week-old mice genetically deficient in foxj1. The foxj1-null oviduct lacks the differentiation of ciliated cells and exhibits the nonciliated phenotype in all epithelial cells (Chen et al. 1998 , Brody et al. 2000 . In the wild-type mouse oviduct, -tubulin IV and foxj1 were expressed in ciliated epithelial cells, but not in the foxj1-null oviduct (data not shown, Okada et al. 2004) . Expression of c-jun was detected in only nonciliated epithelial cells (arrowheads) of the ampulla (AMP) region where the protein was down-regulated in ciliated cells of the wild-type oviduct (Fig. 6A) . Interestingly, in the foxj1-null oviduct, the persistent expression of c-jun was exhibited in all AMP epithelial cells (Fig. 6B) . Thus foxj1-inducing ciliogenesis is required for the reduction of c-jun in oviduct differentiation.
Discussion
E2 induces epithelial cell proliferation with the increased expression of AP-1 transcription factors in the rat and mouse uterus (Loose-Mitchell et al. 1988 , Weisz & Bresciani 1988 , Webb et al. 1990 , Chiappetta et al. 1992 , Kamiya et al. 1996 . In the chick oviduct, however, AP-1 transcription factors are reduced following E2 treatment and induced by an antiestrogen tamoxifen (Cohrs et al. 1988 , Lau et al. 1990 . It has been speculated that the reduction of AP-1 transcription factors in the chick oviduct are related to the differentiation of secretory epithelial cells since it accompanies the elevation of ovalbumin expression. In this study, in order to determine the relationship between AP-1 transcription factor expression, cell proliferation, and differentiation, we used neonatal rat oviducts which had been treated with E2 for 5 days starting at the day of birth. The results showed that cell proliferation and ciliated cell differentiation occurred in specific oviduct regions (Okada et al. 2004) . We evaluated the effect of E2 on the expression of c-jun and c-fos mRNAs in the whole oviduct, including all regions. We found, after E2 treatment on ND 5, that expression of these AP-1 mRNAs did not change (not shown). In the immunohistochemical study, however, the region-and cell type-dependent change in their proteins was exhibited in the ND 5 rat oviduct treated with E2. Additionally, following E2 treatment, epithelial cell proliferation was induced along with higher expression of c-jun and c-fos in the IST/UTJ region, whereas in the INF/AMP region, ciliated epithelial cell differentiation was induced concurrently with reduced expression of c-jun and c-fos. Thus, early in differentiation, the role of AP-1 induction by E2 is likely to be similar to that in the uterus, suggesting that c-jun and c-fos have a regulatory role in cell proliferation in the oviduct epithelium. However, after cell proliferation, the subsequent AP-1 reduction suggests a regulated stage of transition and maturation for the ciliated epithelial cells. Changes caused by E2 were diminished by concomitant treatment with a pure ER antagonist ICI, indicating that E2 acts throughout ER signaling. In the neonatal rat oviduct, ER was expressed in all epithelial cells, but ER was not even after E2 treatment (Yamashita et al. 1989 , Okada et al. 2003 . These findings suggest that the main target receptor of E2 in the neonatal rat oviduct is ER . Taken together, transcription of AP-1 transcription factors are increased by an E2-ER complex via ERE in the primary proliferation phase, and decreased with transition to the secondary differentiation phase. Our previous study indicates that epithelial ER in the neonatal rat oviduct disappears during differentiation to ciliated cells which results in the loss of responsiveness to E2-inducing AP-1 expression via ERE.
The molecular mechanism of the transition of proliferation to differentiation is unknown. However, foxj1 is a key transcription factor for differentiation to ciliated epithelial cells. The ciliated epithelial cells of foxj1-deficient mice lack differentiation (Chen et al. 1998 , Brody et al. 2000 . Moreover, in the oviduct, foxj1 expression was detected at ND 0, prior to the appearance of cilia in epithelial cells. This expression was induced by E2 in the epithelial cells of the INF/AMP region upon the appearance of ciliated cells (Okada et al. 2004) . The persistent expression of c-jun in all epithelial cells (nonciliated cells) in the foxj1-null oviduct suggests that foxj1 induction of ciliated cell differentiation is required for the reduction of epithelial c-jun at the INF/AMP. This concept supports previous findings which reported mutually exclusive expression of foxj1 and the cell proliferation marker bromo-deoxyuridine in the lung (Look et al. 2001) . In contrast, although secretory epithelial cells were not found to be induced in this study, the expression of AP-1 proteins and ER in secretory (nonciliated) epithelial cells of the mature rat oviduct have been reportedly maintained (Mowa & Iwanaga 2000 , Okada et al. 2003 . The activation of ovalbumin gene expression by the ER/c-jun/c-fos complex (Gaub et al. 1990) supports the concept that AP-1 proteins and ER may be essential for secretory cell function. For example, in the epithelium of the vas deferens, androgen increases AP-1 activity prior to cell proliferation and decreases it when differentiation occurs (Darne et al. 2000) . Taken together, AP-1 transcription factors play an important role in sex steroid hormone-regulated proliferation, differentiation, and function of the epithelium in male and female reproductive organs.
In summary, this study suggests that AP-1 transcription factors direct proliferation, differentiation, and function of the epithelial cells in a region-and cell-dependent manner. This study serves as a fundamental tool to enable the understanding of the molecular and cellular mechanisms of epithelial cell differentiation and proliferation of the neonatal rat oviduct. Based on this and our previous studies, we hypothesize that in early neonatal development, the initiation of E2 production and the concomitant increase in oviductal ER expression (Okada et al. 2003) induce foxj1 expression in the programmed ciliated cells of the INF/AMP with a loss of ER and a subsequent reduction of AP-1 transcription factors which sequentially promote epithelial ciliogenesis (Okada et al. 2004) . However, although the stimulation of ER signaling accelerates the differentiation process of ciliated epithelial cells, we suggested that it is not fundamentally required for this event because of the presence of cilia in the ER -deficient oviduct (Okada et al. 2004 ). Also, it should be considered that the expression level of epithelial c-fos and c-jun, and their subsequent responsiveness to E2 were altered in the uterus of mice treated neonatally with 4 µg DES for 5 days, starting at birth (Yamashita et al. 2001 (Yamashita et al. , 2003 . Thus our system using neonatal rats treated with 10 µg of E2 could possibly represent a pharmacological condition rather than a physiological one. Further evaluation of the relationship between regulatory proteins in the oviduct is required to elucidate these mechanisms physiologically.
